BLNC — Balance Labs Income Statement
0.000.00%
Last trade - 00:00- $3.97m
- $6.41m
Annual income statement for Balance Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1 | 0.625 | 0.247 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.387 | 0.56 | 0.187 | 0.116 | 0.271 |
| Operating Profit | 0.613 | 0.064 | 0.06 | -0.116 | -0.271 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.351 | -0.809 | -0.768 | -0.382 | -0.528 |
| Net Income After Taxes | 0.351 | -0.809 | -0.768 | -0.382 | -0.528 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.358 | -0.797 | -0.768 | -0.382 | -0.528 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.358 | -0.797 | -0.768 | -0.382 | -0.528 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.017 | -0.029 | -0.039 | -0.018 | -0.024 |